Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Recombinant DNA01:09

Recombinant DNA

Overview
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
Bioreactor Controls-III01:22

Bioreactor Controls-III

Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Upstream Processing01:27

Upstream Processing

Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of Ogataea polymorpha DUR31 TPP riboswitch as a tool to downregulate gene expression in the yeast Komagataella phaffii.

New biotechnology·2026
Same author

Thermal stress-induced metabolic reprogramming in two hard coral species.

iScience·2026
Same author

Evaluation of recombinant trypsinogen and chymotrypsinogen production in Komagataella phaffii through co-expression of HAC1 and PDI1.

Microbial cell factories·2026
Same author

Non-agricultural feedstocks for next-generation biomanufacturing with yeasts.

Current opinion in biotechnology·2026
Same author

Rapid quantitative bioanalysis using LC-HRIM-QTOFMS with flexible sample delivery and variable traveling wave profiles.

Analytica chimica acta·2026
Same author

Bioconversion of the C1 substrate methanol to succinic acid with engineered Komagataella phaffii.

Bioresource technology·2026

Related Experiment Video

Updated: May 26, 2026

Expression of Recombinant Proteins in the Methylotrophic Yeast Pichia pastoris
09:46

Expression of Recombinant Proteins in the Methylotrophic Yeast Pichia pastoris

Published on: February 25, 2010

Recombinant protein production in yeasts.

Diethard Mattanovich1, Paola Branduardi, Laura Dato

  • 1Department of Biotechnology, University of Natural Resources and Life Sciences, and Austrian Centre of Industrial Biotechnology, Vienna, Austria.

Methods in Molecular Biology (Clifton, N.J.)
|December 14, 2011
PubMed
Summary

Yeast cell factories offer advantages for recombinant protein production, combining fast growth with eukaryotic features for complex protein processing. Engineering yeast glycosylation and utilizing systems biotechnology will advance future protein manufacturing.

More Related Videos

A Convenient and General Expression Platform for the Production of Secreted Proteins from Human Cells
07:09

A Convenient and General Expression Platform for the Production of Secreted Proteins from Human Cells

Published on: July 31, 2012

Protein Engineering by Yeast Surface Display
05:49

Protein Engineering by Yeast Surface Display

Published on: November 29, 2024

Related Experiment Videos

Last Updated: May 26, 2026

Expression of Recombinant Proteins in the Methylotrophic Yeast Pichia pastoris
09:46

Expression of Recombinant Proteins in the Methylotrophic Yeast Pichia pastoris

Published on: February 25, 2010

A Convenient and General Expression Platform for the Production of Secreted Proteins from Human Cells
07:09

A Convenient and General Expression Platform for the Production of Secreted Proteins from Human Cells

Published on: July 31, 2012

Protein Engineering by Yeast Surface Display
05:49

Protein Engineering by Yeast Surface Display

Published on: November 29, 2024

Area of Science:

  • Biotechnology and Molecular Biology
  • Industrial Microbiology

Background:

  • Recombinant protein production is a significant global market, with host selection being critical for new product development.
  • Yeast expression systems offer a balance of single-cell advantages (growth, genetic manipulation) and eukaryotic features (secretion, processing, post-translational modifications).

Purpose of the Study:

  • To review the advantages and limitations of key yeast hosts for heterologous protein production.
  • To highlight the importance of engineering yeast glycosylation for producing human-like glycoproteins.
  • To discuss cellular engineering and process design for improved recombinant protein productivities.

Main Methods:

  • Review of existing literature on yeast expression systems.
  • Analysis of Saccharomyces cerevisiae, Pichia pastoris, and Hansenula polymorpha for large-scale protein production.
  • Discussion of systems biotechnology and genome-scale analyses.

Main Results:

  • Yeast cell factories are promising for recombinant protein production due to their unique combination of features.
  • Engineering yeast glycosylation is crucial for producing specific glycoprotein structures.
  • Advancements in sequencing and systems biotechnology are expected to accelerate yeast-based production.

Conclusions:

  • Yeast hosts like S. cerevisiae, P. pastoris, and H. polymorpha are vital for industrial recombinant protein production.
  • Ongoing research in cellular engineering and process optimization is key to enhancing productivity.
  • Future developments in systems biotechnology will further drive innovation in yeast cell factories.